lectin
deriv
plant
microbi
sourc
constitut
vital
class
entri
inhibitor
target
oligomannos
residu
hiv
envelop
despit
potenc
specif
success
lectinbas
entri
inhibitor
may
imped
issu
regard
econom
product
formul
potenti
mitogen
therefor
exist
gap
hiv
therapeut
pipelin
underscor
need
mass
produc
synthet
broadspectrum
biocomptabil
inhibitor
hiv
entri
present
develop
polymer
synthet
lectin
base
benzoboroxol
bzb
exhibit
weak
affin
nonreduc
sugar
similar
found
hiv
envelop
high
molecular
weight
bzbfunction
polym
demonstr
antivir
activ
increas
increas
ligand
densiti
molecular
weight
polym
construct
reveal
polyval
improv
activ
polym
show
signific
increas
activ
mol
bzb
function
ec
nm
respect
increas
mole
function
result
increas
ec
nm
like
due
elong
rigid
structur
polym
chain
compel
electrostat
repuls
boron
acid
group
increas
molecular
weight
polym
mol
bzb
function
show
gradual
signific
increas
antivir
activ
highest
activ
seen
kda
polym
ec
nm
cem
cell
nm
tzmbl
cell
supplement
polym
backbon
mol
sulfon
acid
increas
aqueou
solubl
polym
least
also
demonstr
synergist
increas
antihiv
activ
nm
tzmbl
cell
possibl
due
electrostat
interact
neg
charg
polym
backbon
posit
charg
benzoboroxolesulfon
acid
copolym
show
decreas
activ
presenc
semin
concentr
fructos
p
addit
copolym
exhibit
minim
effect
cellular
viabil
barrier
properti
cytokin
level
human
reconstruct
ectocerv
tissu
day
repeat
exposur
show
pronounc
activ
varieti
rna
dna
virus
therapeut
perspect
step
hiv
lifecycl
provid
opportun
pharmaceut
intervent
amongst
initi
step
hiv
infect
bind
event
occur
receptor
viral
envelop
surfac
protein
target
cell
hiv
envelop
among
heavili
glycosyl
protein
known
mankind
hiv
iiib
potenti
nlink
glycosyl
site
site
contain
complextyp
oligosaccharid
remain
site
contain
hybrid
andor
high
mannosetyp
structur
report
antivir
activ
lectinbas
entri
inhibitor
suggest
target
oligomannos
region
potenti
produc
broad
spectrum
entri
inhibitor
capabl
inactiv
hiv
independ
tropism
strain
prolong
exposur
agent
virusinfect
cell
caus
caus
deglycosyl
viral
envelop
creat
virion
highli
suscept
neutral
immunogen
respons
mutat
virion
also
lack
resist
small
molecul
entri
inhibitor
therefor
lectinbas
target
entri
inhibitor
repres
interest
class
antiretrovir
agent
potenati
inactiv
hiv
vagin
lumen
even
reach
suscept
cell
prevent
maletofemal
heterosexu
hiv
transmiss
entri
inhibitor
except
maraviroc
fuzeon
test
clinic
trial
fail
like
due
nonspecif
interact
cell
surfac
andor
suboptim
efficaci
consequ
limit
number
clinic
candid
target
hiv
entri
comparison
agent
target
enzymat
machineri
involv
viral
replic
carbohydr
bind
protein
cbp
nonhuman
natur
occur
lectin
protein
mbl
cyanovirinn
cvn
griffithsin
bind
highmannos
oligosaccharid
found
demonstr
abil
inhibit
hiv
infect
vitro
ex
vivo
irrespect
cell
type
coreceptor
tropism
viral
strain
howev
unaccept
high
cost
larg
scale
product
purif
proteinbas
lectin
ad
lowstabl
plausibl
immunogen
respons
may
limit
use
microbicid
polyval
mechan
capit
cbp
pertain
simultan
interact
multiplelink
ligand
receptor
repeat
epitop
found
hiv
envelop
due
translat
entrop
advantag
steric
stabil
polyval
interact
may
enhanc
bind
affin
weak
ligand
inspir
natur
adapt
har
polyval
interact
mechan
enhanc
weak
bind
affin
ligandreceptor
pair
aim
develop
synthet
polyval
inhibitor
hiv
entri
target
highdens
glycosyl
site
viral
envelop
fig
b
phenylboron
acid
pba
form
revers
coval
complex
cisdiol
common
chemic
entiti
found
glycoprotein
eg
mannos
galactos
nacetylneuramin
acid
fucos
residu
presenc
endstand
multipl
mannos
residu
hybrid
andor
complextyp
nlink
glycan
suggest
multipl
bind
site
pbacontain
ligand
pbacontain
polym
demonstr
abil
bind
glycosyl
protein
interact
boron
acid
glycan
yet
exploit
mechan
attenu
hiv
entri
pba
cisdiol
form
hydrolyt
stabl
complex
boron
acid
exist
tetrahedr
form
mostli
preval
ph
valu
greater
pka
pba
pba
without
substitut
aromat
ring
pka
therefor
found
bind
strongli
diol
alkalin
ph
order
improv
bind
physiolog
ph
research
investig
variou
method
facilit
format
stabl
tetrahedr
boron
speci
neutral
ph
lower
pka
dativ
bond
form
boron
multival
addit
electronwithdraw
group
hydroxymethyl
fluoro
nitro
phenyl
ring
pba
found
improv
bind
diol
physiolog
ph
compar
unsubstitut
pba
benzoboroxol
orthohydroxymethyl
phenylboron
acid
bzb
fig
demonstr
strong
bind
reduc
sugar
like
fructos
also
capabl
bind
glycopyranosid
like
galactopyranos
nonreduc
sugar
structur
similar
found
termin
glycan
residu
neutral
ph
owe
eas
synthesi
stabil
improv
affin
termin
sugar
residu
neutral
ph
work
focus
investig
bzb
hiv
entri
inhibitor
past
laboratori
shown
bzb
ligand
capabl
bind
termin
sugar
residu
nlink
glycan
multival
polym
bzb
copolymer
watersolubl
nontox
methacrylamid
hpmam
monom
show
crossclad
antivir
activ
nanomolar
low
micromolar
concentr
base
investig
evalu
effect
mole
function
bzb
antivir
activ
synthet
lectin
chose
mol
bzb
polym
assess
howev
previou
system
involv
problem
regard
solubl
activ
addit
need
biocompat
evalu
hypothes
incorpor
negativelycharg
moieti
would
improv
affin
electrostat
interact
posit
charg
loop
improv
solubl
steric
avail
reactiv
boron
moieti
work
therefor
pertain
modul
multipl
ligand
densiti
charg
ligand
present
polym
backbon
augment
entri
inhibit
activ
synthet
lectin
current
work
investig
effect
ligand
densiti
bzb
mole
incorpor
b
molecular
weight
bzb
polym
c
activ
polyval
synthet
lectin
sulfon
polym
backbon
inhibit
hiv
entri
addit
also
assay
influenc
fructos
role
bind
kinet
antivir
activ
bzb
polym
alizarin
red
phenylboron
acid
phenylboron
acid
diol
purchas
acro
use
receiv
water
doubl
distil
milliq
filtrat
system
acid
amp
aibn
recrystal
chloroform
dissolv
recrystal
prior
use
free
radic
polymer
chemic
reagent
purchas
aldrich
st
loui
mo
acro
morri
plain
nj
use
without
purif
unless
otherwis
note
arsbas
bind
assay
perform
describ
wang
et
al
briefli
solut
ar
dye
freshli
prepar
mm
ph
phosphat
buffer
mm
stock
solut
bzb
prepar
solut
ar
ph
solut
readjust
use
plate
vari
amount
bzb
solut
ad
ar
solut
obtain
rang
concentr
bzb
maintain
concentr
ar
constantli
plate
allow
shake
sec
prior
measur
fluoresc
measur
excit
wavelength
nm
emiss
nm
experi
carri
triplic
absorb
spectra
collect
nm
associ
constant
pba
bzb
ar
determin
plot
invers
chang
fluoresc
vs
invers
concentr
boron
acid
quotient
yintercept
slope
line
use
comput
k
boron
acidar
complex
valid
assay
first
determin
effect
vari
concentr
pba
absorb
fluoresc
intens
ar
ar
show
color
chang
red
yellow
increas
fluoresc
intens
ph
associ
constant
pbaar
complex
determin
consist
valu
report
literatur
follow
solut
vari
concentr
diol
dfructos
glucos
sialic
acid
prepar
mm
ph
phosphat
buffer
contain
ar
mm
pba
bzb
solut
contain
excess
diol
titrat
boron
acidar
complex
diol
replac
ar
form
boron
aciddiol
complex
concentr
free
ar
solut
increas
therebi
show
mark
decreas
fluoresc
shift
fluoresc
use
comput
associ
constant
boron
aciddiol
complex
bzb
monom
polym
synthes
use
method
similar
describ
previous
briefli
polym
prepar
free
radic
polymer
mol
mol
mol
mol
bzb
feed
ratio
presenc
mol
aibn
watersolubl
nontox
use
backbon
monom
copolymer
fig
reaction
mixtur
purg
nitrogen
degass
hr
ice
follow
reaction
move
oil
bath
hr
polym
precipit
anhydr
ether
use
fraction
precipit
techniqu
polym
centrifug
purifi
use
dialysi
across
mwco
membran
use
vivaflow
dialysi
system
polym
vari
molecular
weight
synthes
describ
mol
feed
ratio
bzb
vari
feed
ratio
aibn
mol
mol
polym
sulfon
acid
also
synthes
use
condit
describ
degre
substitut
determin
h
nmr
mercuri
mhz
spectromet
varian
found
correl
feed
ratio
tabl
molecular
weight
determin
gpc
gpc
agil
technolog
santa
clara
ca
equip
organ
column
plgel
mix
bed
polym
laboratori
amherst
differenti
refract
index
detector
bidndc
brookhaven
instrument
holtsvil
ny
multiangl
light
scatter
detector
bimwa
brookhaven
instrument
holtsvil
ny
antihiv
activ
synthet
lectin
polym
evalu
use
singlecycl
infect
inhibit
assay
tzmbl
cell
wellcharacter
tropic
clade
c
viru
isol
sexual
transmit
viru
infect
cultur
pbmc
use
neutral
assay
addit
tro
clade
c
pseudotyp
weau
clade
b
viral
strain
assay
investig
crossclad
crosstrop
activ
polym
solut
prepar
mgml
dmem
gl
dglucos
mgml
sodium
pyruv
lglutamin
invitrogen
carlsbad
ca
ph
adjust
necessari
pasteur
min
pasteur
stock
solut
dilut
dmem
contain
nutrient
dmem
supplement
fetal
bovin
serum
hyclon
logan
ut
mm
hepe
gibcoinvitrogen
carlsbad
ca
gentamicin
sigma
st
loui
mo
steril
condit
prepar
design
pasteur
polym
without
protein
present
media
final
media
composit
dilut
fb
mm
hepe
gentamicin
assay
conduct
plate
polym
solut
highest
concentr
ad
bottom
row
bottom
row
plate
test
sampl
ad
prior
row
growth
media
creat
dilut
scheme
serial
dilut
repeat
five
time
obtain
doserespons
curv
appropri
cell
control
viru
control
includ
plate
follow
serial
dilut
cellfre
viru
tcid
ad
well
except
well
serv
cell
control
plate
incub
hr
co
incub
preincub
tzmbl
cell
suspens
prepar
densiti
cellsml
growth
media
contain
deae
dextran
ad
well
incub
addit
hr
luminesc
measur
min
incub
britelit
reagent
perkinelm
waltham
toxic
sampl
simultan
analyz
use
ident
plate
layout
absenc
viru
determin
loss
cell
viabil
luminesc
sampletr
well
compar
cell
control
ec
report
concentr
sampl
reduc
rel
luminesc
unit
rlu
compar
viru
control
dose
respons
curv
fit
percent
neutral
data
use
graphpad
prism
softwar
graph
pad
lajolla
ca
assay
evalu
effect
preincub
time
antivir
activ
synthet
lectin
assay
conduct
use
procedur
similar
one
describ
except
preincub
time
polym
solut
incub
min
viru
prior
addit
tzmbl
cell
assay
evalu
effect
fructos
mgml
fructos
solut
prepar
dmem
media
polym
solut
fructos
solut
ad
along
viru
creat
fructos
concentr
mgml
remain
step
perform
describ
antihiv
activ
cytotox
also
evalu
laboratori
strain
iiib
strain
rod
human
tlymphocyt
cem
cell
cultur
briefli
viru
stock
titrat
human
tlymphocyt
cem
cell
express
cell
cultur
infect
dose
ccid
ccid
viru
dose
infect
cell
cultur
cem
cell
suspend
cultur
medium
cellsml
infect
hiv
ccid
immedi
viral
exposur
cell
suspens
place
well
flatbottom
microtit
tray
contain
variou
concentr
test
compound
incub
period
giant
cell
format
microscop
determin
compound
test
parallel
potenti
cytostat
effect
uninfect
cem
cell
cultur
cocultiv
assay
persist
infect
cell
design
mix
cell
along
appropri
concentr
test
compound
h
mark
syncytium
format
note
control
cell
cultur
number
syncytia
determin
microscop
ec
defin
compound
concentr
requir
prevent
syncytium
format
antivir
assay
base
inhibit
virusinduc
cytopath
hel
herp
simplex
viru
type
g
vaccinia
viru
vesicular
stomat
viru
vero
coxsacki
punta
toro
viru
hela
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
crfk
felin
corona
viru
fipv
felin
herp
viru
cell
cultur
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
presenc
vari
concentr
nm
test
compound
viral
cytopath
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
triplic
solut
bzb
amp
hpma
mgml
prepar
serum
contain
media
polym
solut
pasteur
min
media
contain
polym
appli
apic
surfac
tissu
cultur
plate
insert
three
repeat
exposur
test
sampl
perform
interv
h
h
exposur
tissu
viabil
determin
use
mtt
assay
chang
tissu
morpholog
evalu
histolog
examin
epithelium
day
cytokin
level
assay
use
elisa
level
measur
tissu
cultur
supernat
util
human
cytokin
kit
r
system
tissu
integr
monitor
measur
transepithelium
electr
resist
teer
triplic
control
solut
phpma
mgml
mgml
cultur
medium
also
perform
measur
affin
boron
acid
ligand
reduc
nonreduc
sugar
residu
use
arsbas
threecompon
colorimetr
bind
assay
affin
glucos
fructos
sialic
acid
assay
ensur
viabil
assay
associ
constant
pbaar
compar
valu
report
literatur
wang
cowork
tabl
summar
associ
constant
pba
bzb
variou
diol
comparison
pba
bzb
affin
simpl
reduc
sugar
reveal
fourfold
stronger
affin
bzb
fructos
compar
pba
howev
affin
bzb
pba
glucos
compar
unsubstitut
pba
demonstr
minim
affin
nonreduc
sugar
neutral
ph
contrast
bzb
reveal
higher
still
weak
affin
nonreduc
complex
sugar
develop
boron
acid
base
synthet
entri
inhibitor
hiv
exploit
abil
bzb
bind
nonreduc
sugar
structur
similar
termin
sugar
moieti
found
high
mannos
complextyp
nlink
glycan
previous
confirm
observ
also
use
surfac
plasmon
reson
spr
bzb
show
k
mm
hiv
bal
wherea
measur
bind
observ
pba
unsubstitut
pbacontain
polym
demonstr
abil
bind
glycosyl
protein
alkalin
ph
wherea
bzb
bind
glycosid
neutral
ph
differ
ascrib
presenc
oxygen
ortho
substitu
stabil
boron
ester
toward
hydrolysi
decreas
energi
barrier
tetrahedr
format
bzb
show
superior
bind
affin
sugar
residu
compar
unsubstitut
pba
bind
fairli
weak
practic
applic
regard
polyval
commonli
exploit
improv
bind
affin
weak
ligand
effect
wellknown
natur
proteinligand
interact
well
synthet
protein
mimic
kaur
et
al
demonstr
almost
doubl
increas
affin
glucos
tweezerlik
bisboron
acid
molecul
compar
monoval
boron
acid
incorpor
ligand
polym
backbon
provid
synthet
access
mechan
increas
affin
ligand
glycoprotein
tabl
ii
summar
molecular
weight
polym
synthes
freerad
polymer
determin
use
size
exclus
chromatographi
agil
technolog
santa
clara
ca
equip
plgel
mixedb
column
polym
lab
amherst
differenti
refract
index
detector
bidndc
brookhaven
instrument
holtsvil
ny
multiangl
light
scatter
detector
bimwa
brookhaven
instrument
holstvil
ny
mole
function
bzb
polym
determin
use
h
nmr
bind
affin
bzb
nonreduc
sugar
determin
arsbas
colorimetr
assay
spr
reveal
weak
affin
tabl
high
molecular
weight
polym
polyval
present
bzb
show
log
scale
increas
activ
ec
low
micromolar
nanomolar
rang
seen
fig
log
scale
increas
antivir
activ
observ
increas
bzb
mole
function
mol
mol
polym
student
ttest
p
increas
bzb
function
mol
mol
show
margin
increas
activ
student
ttest
p
contrari
increas
ligand
densiti
mol
mol
show
reduct
abil
polym
neutral
hiv
entri
student
ttest
p
antihiv
activ
compar
mol
bzbfunction
polym
believ
increas
antivir
activ
increas
mole
function
explain
least
two
distinct
mechan
describ
mammen
cowork
polyval
steric
stabil
combin
effect
increas
number
densiti
ligand
like
improv
probabl
bind
therebi
enhanc
bind
antivir
activ
avid
polyval
secondari
mechan
suspect
bzb
present
polym
bind
escort
along
larg
waterswollen
polym
drape
possibl
make
viral
envelop
physic
inaccess
fusion
entri
host
cell
assum
two
mechan
collect
determin
activ
synthet
lectin
gradual
increas
activ
mol
decreas
activ
mol
explain
loss
steric
stabil
effect
polym
increas
ligand
densiti
polym
increas
neg
charg
boron
could
repel
therebi
distort
polym
conform
effect
random
coil
structur
less
effect
rigid
elong
structur
hand
increas
number
avail
ligand
therefor
point
attach
polym
could
result
collaps
polym
structur
compromis
abil
polym
steric
stabil
bind
surfac
although
rel
contribut
abovement
two
mechan
toward
antivir
activ
yet
elucid
reason
assum
steric
stabil
play
critic
role
govern
abil
bzbfunction
polym
block
hiv
entri
base
result
assess
perform
mol
function
bzb
polym
depend
coreceptor
tropism
clade
hiv
display
signific
variat
differ
area
viral
envelop
make
import
evalu
crossclad
andtrop
activ
new
therapeut
agent
exampl
agent
target
posit
charg
loop
nonspecif
sulfat
polym
show
sever
compromis
activ
tropic
strain
coreceptor
tropism
viru
impact
extent
posit
charg
loop
coreceptortrop
strain
exhibit
posit
charg
strain
previous
report
antivir
activ
bzbhpma
copolym
mol
bzb
mole
incorpor
hiv
strain
across
clade
tropism
assay
perform
use
clade
b
clade
c
tro
isol
acut
sexual
transmit
infect
pseudotyp
clade
b
weau
independ
ligand
densiti
bzb
polym
show
compar
antivir
activ
across
clade
tropism
hiv
although
hiv
envelop
exhibit
domain
heterogen
across
viral
strain
mani
nlink
glycan
believ
fairli
conserv
provid
potenti
mechan
observ
broad
spectrum
activ
lectin
understand
ligand
densiti
affect
activ
bzb
function
polym
next
interest
explor
influenc
molecular
weight
polym
fix
bzb
function
antivir
activ
synthet
lectin
bzb
function
polym
mol
synthes
use
vari
concentr
initi
yield
polym
rang
molecular
weight
shown
fig
ec
polym
decreas
thu
higher
activ
nm
kda
bzb
nm
kda
bzb
student
ttest
p
owe
increas
number
ligand
avail
bind
per
polym
chain
increas
molecular
weight
polym
fix
percent
bzb
incorpor
show
improv
activ
howev
improv
activ
found
molecular
weight
variat
less
dramat
seen
variat
percent
bzb
function
entri
inhibit
activ
lectin
origin
abil
bind
glycan
spike
viral
surfac
sever
envelop
virus
bear
carbohydr
shield
envelop
could
effect
target
use
lectin
nonspecif
bind
carbohydr
therefor
other
field
test
activ
plant
bacteri
andor
synthet
lectin
lentivirus
hsv
hivspecif
activ
observ
synthet
lectin
attribut
fact
viru
test
assay
exhibit
compar
extent
glycosyl
site
andor
similar
natur
glycan
ie
highmannosetyp
hiv
sinc
interact
polyval
construct
bzbbase
synthet
lectin
viral
envelop
depend
multitud
factor
densiti
glycosid
viral
surfac
degre
oligomer
glycoprotein
spatial
arrang
saccharid
flexibl
conceiv
synthet
lectin
select
inhibit
virus
particular
case
hiv
type
virus
bear
glycosyl
envelop
lead
polym
studi
antivir
activ
nm
bzb
bzb
show
pooraqu
solubl
mgml
consid
activ
bzb
polym
could
compromis
presenc
protein
compon
vagin
environ
improv
aqueou
solubl
polym
may
requir
order
deliv
requir
drug
concentr
kataoka
et
al
other
demonstr
incorpor
amin
pbacontain
polym
could
lower
pka
boron
acid
around
therebi
enhanc
solubl
incorpor
amin
also
util
winblad
et
al
reduct
amin
acid
polylysinepeg
backbon
pka
polym
address
poor
aqueou
solubl
polym
high
benzoboroxol
function
mol
andor
high
molecular
weight
polym
kda
synthes
polym
mole
sulfon
acid
amp
anion
monom
incorpor
amp
copolym
add
charg
otherwis
neutral
hpma
backbon
increas
aqueou
solubl
polym
neutral
ph
nearli
increas
aqueou
solubl
observ
incorpor
amp
sinc
amp
bzb
bind
test
polym
individu
physic
mixtur
copolym
amp
bzb
bzb
function
mol
amp
mol
hpma
polym
shown
dose
respons
curv
shown
fig
physic
mixtur
two
polym
bzb
amp
demonstr
signific
increas
activ
student
ttest
p
data
suggest
presenc
amp
polym
solut
influenc
bind
bzb
contrast
amp
bzb
copolymer
result
polym
show
log
scale
decreas
ec
student
ttest
p
believ
presenc
simultan
ionic
coval
interact
b
steric
stabil
c
entrop
advantag
multipl
bind
event
may
contribut
observ
synergist
improv
antivir
activ
copolym
physic
mixtur
charg
sulfon
polym
backbon
like
facilit
initi
ionic
interact
loop
therebi
steric
facilit
coval
interact
bzb
polym
glycan
impli
irrespect
bind
affin
bind
event
would
bring
along
larg
polym
drape
viral
surfac
thu
inhibit
interact
host
cell
bzbamp
copolym
show
activ
concentr
nm
compar
cbp
cvn
nm
compound
also
evalu
potenti
prevent
syncytium
format
cocultur
persist
iiib
infect
uninfect
sup
cell
found
display
ec
nm
sulfat
anion
polym
previous
evalu
microbicid
target
loop
awar
issu
associ
sulfon
polym
microbicid
applic
includ
toxic
due
nonspecif
bind
tropismspecif
activ
loss
antivir
activ
presenc
semen
attempt
address
issu
synthes
polym
small
amount
amp
copolymer
biocompat
hpmam
like
reduc
potenti
toxic
furthermor
primari
mechan
action
synthet
lectin
abil
bzb
coval
bind
demonstr
clade
tropism
independ
activ
ionic
interact
amp
loop
auxiliari
mechan
action
augment
overal
activ
bzbbase
synthet
lectin
summari
incorpor
amp
bzb
yield
polym
enhanc
aqueoussolubl
gener
heteromer
polyval
present
ligand
superior
bind
bzb
polym
retain
activ
presenc
semin
concentr
fructos
next
interest
ask
whether
activ
polym
govern
thermodynam
alon
whether
bind
kinet
also
influenc
entri
inhibit
activ
bzb
evalu
effect
bind
kinet
bzbapm
copolym
sampl
preincub
virion
min
shown
fig
irrespect
incub
time
copolym
sampl
show
inhibit
hiv
nm
student
ttest
p
unlik
dmannos
oligomerspecif
plant
lectin
whose
antivir
activ
pronounc
upon
hr
preincub
time
viru
bzbbase
synthet
lectin
show
superior
rapid
inhibit
hiv
entri
irrespect
preincub
viru
particl
sever
antivir
agent
sulfat
polym
intend
deliv
vagin
show
compromis
complet
loss
antivir
activ
presenc
semin
fluid
semin
fluid
rich
sourc
protein
enzym
salt
immun
cell
sugar
presenc
high
concentr
simpl
sugar
fructos
especi
may
rais
concern
lectinbas
therapeut
seen
result
ar
assay
bzb
show
except
high
affin
fructos
therefor
test
abil
bzb
amp
enabl
research
microbicid
develop
requir
care
determin
interact
bzb
polym
epitheli
cell
cervicovagin
tissu
may
impact
viabil
cytokin
product
owe
abil
bzb
bind
glycoprotein
abil
sulfon
acid
nonspecif
bind
posit
charg
surfac
critic
assess
safeti
bzbamp
copolym
vagin
tissu
tissu
purchas
mattek
corpor
serv
suitabl
model
evalu
tissuelevel
toxic
topic
microbicid
seen
fig
bzbamp
copolym
show
signific
loss
tissu
viabil
compar
nontox
hpma
control
even
concentr
vitro
ec
hour
exposur
viabil
irrit
potenti
test
polym
evalu
elisa
inflammatori
cytokin
associ
mucos
toxic
ie
use
human
cytokin
kit
r
system
investig
biocompat
reveal
signific
alter
tissu
viabil
cytokin
level
tissu
morpholog
barrier
properti
epithelium
summari
result
suggest
polym
function
bzb
moieti
like
nontox
like
high
therapeut
index
allow
higher
concentr
polym
dose
safe
therebi
minim
impact
compet
bind
site
may
present
vagin
environ
work
relev
develop
new
agent
capabl
render
viru
inact
femaletomal
heterosexu
transmiss
ideal
microbicid
candid
must
exhibit
potenc
crossclad
broad
spectrum
activ
select
inhibit
pathogen
mass
produc
biocompat
current
research
cbp
suggest
possess
sever
favor
properti
qualifi
potenti
microbicid
candid
success
larg
imped
potenti
mitogen
properti
cost
product
isol
purif
mass
quantiti
regard
approach
develop
synthet
lectin
use
bzb
moieti
meet
criteria
ideal
microbicid
bzb
readili
incorpor
varieti
biocompat
polym
backbon
polymer
construct
synthet
modifi
enhanc
activ
specif
addit
bzbbase
synthet
lectin
also
present
afford
scalabl
product
could
deliv
pandem
region
determin
fit
sigmoid
doserespons
curv
variabl
hill
slope
singl
factor
anova
show
signific
differ
group
p
two
tail
student
ttest
reveal
signific
increas
activ
mol
increas
mol
show
reduct
activ
ec
bzb
hpma
compar
ec
bzb
hpma
n
mean
sd
p
p
effect
molecular
weight
entri
inhibit
activ
bzb
polym
result
singlecycl
infect
inhibit
tzmbl
cell
clade
b
isol
acut
sti
dose
respons
curv
bzb
hpma
polym
vari
molecular
weight
b
ec
determin
fit
sigmoid
doserespons
curv
variabl
hill
slope
two
tail
student
ttest
conduct
n
mean
sd
p
signific
increas
activ
observ
increas
mw
polym
kda
kda
p
respect
highest
activ
observ
kda
mw
polym
nm
determin
fit
sigmoid
doserespons
curv
variabl
hill
slope
two
tail
student
ttest
conduct
n
mean
sd
p
amp
show
ec
nm
physic
mixtur
bzb
hpma
amp
hpma
show
signific
increas
antivir
activ
bzb
hpma
p
howev
copolym
hmpba
amp
mol
function
respect
show
dramat
increas
antivir
activ
ec
nm
suggest
presenc
synergist
activ
hmpba
amp
p
safeti
evalu
bzb
amp
hpma
reconstruct
human
ectocerv
tissu
three
repeat
exposur
phpma
triton
serv
nontox
toxic
control
respect
percentag
viabil
tissu
determin
use
mtt
assay
end
day
b
teer
measur
graph
percentag
notreat
control
day
cf
proinflammatori
cytokin
releas
day
tissu
treat
bzb
amp
hpma
show
symptom
loss
tissu
viabil
elev
cytokin
level
compar
phpmatreat
nontox
control
mean
sd
student
ttest
p
polym
composit
molecular
weight
distribut
